Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Enjoy this offer
* See conditions on site
Capitalization 631.65Cr 53TCr P/E ratio 2024 *
33.9x
P/E ratio 2025 * 26.3x
Enterprise value 747.11Cr 63TCr EV / Sales 2024 *
3.27x
EV / Sales 2025 * 3.03x
Free-Float
80.35%
Yield 2024 *
2.09%
Yield 2025 * 2.18%
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.09%
1 week+0.95%
Current month-1.76%
1 month+1.29%
3 months-7.49%
6 months-18.36%
Current year-3.85%
More quotes
1 week
228.20
Extreme 228.2
235.40
1 month
223.86
Extreme 223.8606
241.64
Current year
223.86
Extreme 223.8606
295.20
1 year
195.10
Extreme 195.1
295.20
3 years
165.30
Extreme 165.3
295.20
5 years
142.40
Extreme 142.4
295.20
10 years
113.25
Extreme 113.25
349.10
More quotes
Director TitleAgeSince
Chief Executive Officer 59 30/19/30
Director of Finance/CFO 60 31/22/31
Chief Operating Officer - 01/22/01
Manager TitleAgeSince
Director/Board Member 69 14/17/14
Chairman 76 30/19/30
Chief Executive Officer 59 30/19/30
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+2.09%+0.95%+4.63%+4.92%631.65Cr
-0.37%+2.23%+13.40%-8.38%20TCr
0.00%+0.12%+9.81%-31.08%12TCr
-0.56%+0.65%-11.50%-10.09%6.77TCr
-1.34%-0.34%+16.66%-1.52%4.73TCr
+0.94%+2.09%+35.53%+94.88%4.7TCr
+0.70%+0.61%+19.47%-11.31%2.93TCr
+1.00%+1.31%-31.55%-48.72%2.79TCr
-0.73%-2.19%+19.32%-1.50%2.74TCr
-0.67%+2.09%+6.49%+13.38%2.41TCr
Average +0.11%+0.76%+8.23%+0.06% 5.95TCr
Weighted average by Cap. -0.18%+1.48%+9.97%-4.97%
See all sector performances
2024 *2025 *
Net sales 226.99Cr 19TCr 239.88Cr 20TCr
Net income 18Cr 1.52TCr 24Cr 1.98TCr
Net Debt 110.6Cr 9.28TCr 94Cr 7.92TCr
More financial data * Estimated data
Logo ConvaTec Group Plc
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (32.5%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (28.4%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence and critical care (21.3%); - infusion (21.3%) ; - other (0.5%). At the end of 2023, the group operated 9 production sites worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (30.2%), Americas (55.4%) and Asia/Pacific (14.4%).
Employees
10,000
More about the company
Date Price Change Volume
13/24/13 234.80 p +2.09% 3,208,928
12/24/12 230.00 p -0.09% 3,389,940
11/24/11 230.20 p -0.86% 2,142,616
10/24/10 232.20 p -0.60% 4,400,350
09/24/09 233.60 p +0.43% 3,452,032

Delayed Quote London S.E., September 13, 2024 at 09:05 pm IST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.086USD
Average target price
3.774USD
Spread / Average Target
+22.29%
Consensus

Quarterly revenue - Rate of surprise

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW